Itau Unibanco Holding S.A. Assembly Biosciences, Inc. Transaction History

Itau Unibanco Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $2,416 - $6,881	-289 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $3,637 - $5,865	-282 Reduced 49.39%	289 $4,000
Q4 2018 Feb 13, 2019	BUY	$19.05 - $36.45 $933 - $1,786	49 Added 9.39%	571 $13,000
Q3 2018 Nov 13, 2018	BUY	$34.41 - $44.23 $17,962 - $23,088	522 New	522 $19,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.